“Guideline values and human risk assessment for the presence of anti-inflammatory drugs remaining in drinking water after lab scale treatment”, Braz. J. Pharm. Sci., vol. 54, no. 1, p. e17320, Jun. 2018, doi: 10.1590/s2175-97902018000117320.